Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis-infected women

Parasite Immunology

Volumn 29, Issue 7, 2007, Pages 359-365

  Yadav, M ^a,b   Dubey, M L ^a,b   Gupta, I ^a   Malla, N ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cysteine proteinase 30; STD; Trichomonas vaginalis; Trichomoniasis

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE 30; CYSTEINE PROTEINASE 30 ANTIBODY; PARASITE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; PRIORITY JOURNAL; SERUM; SYMPTOM; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINA; VAGINA DISCHARGE;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; SPECIMEN HANDLING; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA;

TRICHOMONAS VAGINALIS;

EID: 34250646696     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2007.00952.x     Document Type: Article

References (26)

1. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991 165 : 1168 1176.
2. Weinstock H, Berman S Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004 36 : 6 10.
3. Schwebke J, Venglarik M Morgan S. Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis. J Clin Microbiol 1999 37 : 2369 2370.
4. Bachmann L, Lewis I, Allen R et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health 2000 90 : 1615 1618.
5. Klouman E, Masenga EJ, Klepp KI, Sam NE, Nkya W Nkya C. HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk. J Acquir Immune Defic Syndr Hum Retrovirol 1997 14 : 163 168.
6. Morency P, Dubois MJ, Gresenguet G et al. Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Infect 2001 77 : 125 129.
7. Sharma P, Malla N, Gupta I, Ganguly NK Mahajan RC. Prevalence of trichomoniasis in symptomatic and asymptomatic subjects using different contraceptive devices. Ind J Med Microbiol 1988 6 : 315 322.
8. Malla N, Wattal C, Khan I, Kaul R Raina V. Study of trichomoniasis in Kashmir (North India). Ind J Med Microbiol 1989 7 : 121 126.
9. Vishwanath S, Talwar V, Prasad R, Coyaji K, Elias CJ De Zoysa I. Syndromic management of vaginal discharge among women in reproductive health clinic in India. STD 2000 76 : 303 306.
10. Kiviat NB, Paryonen JA Brockway J. Cytologic manifestations of cervical and vaginal infections: epithelial and inflammatory cellular changes. J Am Med Assoc 1985 253 : 989 996.
11. Alderete JF Garza GE. Specific nature of Trichomonas vaginalis parasitism of host cell surfaces. Infect Immun 1985 50 : 701 708.
12. Valadkhani Z, Sharma S, Harjai K, Gupta I Malla N. In vitro comparative kinetics of adhesive and haemolytic potential of T. vaginalis isolates from symptomatic and asymptomatic females. Ind J Pathol Microbiol 2003 46 : 693 699.
13. Juliano C, Monaco G, Bandiera P, Tedde G Cappuccinelli P. Action of anticytoskeletal compounds on in vitro cytopathic effect, phagocytosis, and adhesiveness of Trichomonas vaginalis. Genitourin Med 1987 63 : 256 263.
14. Arroyo R Alderete JF. Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells. Infect Immun 1989 57 : 2992 2997.
15. Arroyo R, Engbring J Alderete JF. Molecular basis of host epithelial cell recognition by Trichomonas vaginalis. Mol Microbiol 1992 6 : 853 862.
16. Mendoza-Lopez MR, Bercerril-Garcia C, Fattel-Facenda LV et al. CP 30, a cysteine proteinase involved in Trichomonas vaginalis cytoadherence. Infect Immun 2000 68 : 4907 4912.
17. Yadav M, Dubey ML, Gupta I, Bhatti G Malla N. Cysteine proteinase 30 in clinical isolates of T. vaginalis from symptomatic and asymptomatic infected women. Expt Parasitol 2007 (in press). doi: 10.1016/j.exppara.2007.02.007.
18. Sharma P, Malla N, Gupta I, Ganguly NK Mahajan RC. Comparison of wet mount, culture and enzyme linked immunosorbent assay for the diagnosis of trichomoniasis in women. Trop Geogr Med 1991 43 : 257 260.
19. Diamond LS. Serum requirements of axenically cultivated E. histolytica. J Parasitol 1970 56 : 79 81.
20. Lowry OH, Rosenbrough NJ, Farr AD Randall RL. Protein measurement with Folin phenol reagent. J Biol Chem 1951 193 : 265 276.
21. Lockwood BC, North MJ, Scott KI, Bremner AF Coombs GH. The use of a highly sensitive electrophoretic method to compare the proteinases of trichomonads. Mol Biochem Parasitol 1987 24 : 89 95.
22. Provenzano D Alderete JF. Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infect Immun 1995 63 : 3388 3395.
23. Voller A, Bidwell DE Barlett A. Enzyme immunoassay in diagnostic medicine - theory and practice. Bull WHO 1976 53 : 55 65.
24. Sharma P, Malla N, Gupta I, Ganguly NK Mahajan RC. Antitrichomonal IgA antibodies in Trichomoniasis before and after treatment. Folia Microbiol 1991 36 : 302 304.
25. Arroyo R Alderete JF. Two Trichomonas vaginalis surface proteinases bind to host epithelial cells and are related to levels of cytoadherence and cytotoxicity. Arch Med Res 1995 26 : 279 285.
26. Alderete JF, Newton E, Dennis C Neale KA. The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases. Genitourin Med 1991 67 : 469 474.